NEW YORK, March 9 - Invitrogen has sold its Rockville, Md., facility to Human Genome Sciences for $55 million in cash, the company said Friday.

Invitrogen acquired the 240,000 square foot facility in its September 2000 acquisition of Life Technologies, which had it headquarters located at the facility. Invitrogen occupies facilities in five other locations, including a manufacturing site in Frederick County, Md.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.